FCPA Enforcement Driving Compliance Software
www.mainjustice.com, December 15, 2009

Last month, the DOJ’s Assistant Attorney General for the Criminal Division, Lanny Breuer, gave a rousing speech putting the pharmaceutical industry on notice that it would be subject to increased enforcement of international anti-bribery statutes. As Main Justice reported last month, the shifting gears of the DOJ’s amped-up Foreign Corrupt Practices Act enforcement team had targeted an evolving, under-regulated, and increasingly global industry. A 2009 survey by the Pharmaceutical Research and Manufactures of America found that nearly $100 billion, or about one third, of members’ sales were generated outside the U.S., where health systems are regulated and operated by government entities to a greater degree, Breuer said..

Perhaps it was to be expected that what might follow would be an equally rigorous response from the private sector. Tuesday offered one such example. Daylight Forensic & Advisory, a risk management firm run by former FBI special agent Joe Spinelli, has teamed Read More.